Rendering of complexes between SARS-CoV-2 and human proteins, with interface mutations highlighted.

SARS-CoV-2–human protein–protein interactome

A SARS-CoV-2-human protein contactome map uncovers an inhibitor of viral replication

Announcements

  • Symbols related to starting a biotech company

    Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.

  • RNA

    Our annual survey highlights academic startups that are, among other things, designing circular RNA therapeutics, tackling cancer with arenaviruses, creating psychedelics without the trip, editing genes and cells in vivo, harnessing the power of auto-antibodies, editing the epigenome.

Nature Biotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

Nature Careers

Events

Advertisement